Creative Medical Technology Holdings Inc — Cash Flow (NASDAQ:CELZ) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 434.56 K-2.22 M-7.8 M-8.03 M-5.3 M -5.87 M Cash from investing activities 250 K0-10.08 M3.45 M6.32 M 0 Cash from financing activities 693.92 K12.84 M15.47 M-270.95 K1.45 M 4.98 M Free cash flow 434.56 K-2.52 M-7.8 M-8.03 M-5.3 M -5.87 M

News

Creative Medical receives WHO designation for second cell therapy

Creative Medical reports positive interim data for back pain therapy

Creative Medical’s BioDefense initiative receives regulatory approval

Creative Medical Technology stockholders approve warrant exercise proposal

Creative Medical completes enrollment in chronic back pain trial

WHO approves olastrocel as international name for CELZ-201 therapy

Creative Medical Technology Holdings approves bonuses for CEO and CFO

Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now

Creative Medical Technology reports clinical progress in regenerative medicine

FDA grants fast track status to Creative Medical’s disc disease therapy

New Strong Sell Stocks for July 31st

Creative Medical receives patent allowance for diabetes treatment